Clinical Trial Update: A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME [Phase 3]

View source ↗

Summary

Phase 3 study investigating the Port Delivery System delivering ranibizumab for diabetic macular edema, comparing it with standard intravitreal ranibizumab, plu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetic Macular Edema | Phase 3 | Status: RECRUITING